Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19.
Journal: Antimicrobial agents and chemotherapy
Published: July 10, 2026
Pharmacokinetics, Safety, and Tolerability of Obeldesivir in Healthy Japanese and White Participants.
Journal: European journal of drug metabolism and pharmacokinetics
Published: December 06, 2025
SARS-CoV-2 Resistance Analyses From the Phase 3 BIRCH Study of Obeldesivir in High-Risk Nonhospitalized Participants With COVID-19.
Journal: Antiviral research
Published: October 14, 2025
SARS-CoV-2 resistance analyses from the Phase 3 BIRCH study of obeldesivir in high-risk nonhospitalized participants with COVID-19.
Journal: Antiviral research
Published: October 14, 2025
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 25, 2025
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.
Journal: The Lancet. Infectious diseases
Published: December 20, 2024
Clinical Pharmacokinetics and Safety of Remdesivir in Phase I Participants with Varying Degrees of Renal Impairment.
Journal: Clinical pharmacokinetics
Published: October 31, 2024
Clinical Evaluation of Drug-Drug Interactions with Obeldesivir, an Orally Administered Antiviral Agent.
Journal: Clinical pharmacology and therapeutics
Published: October 30, 2024
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 12, 2024
Disseminated tuberculosis in a lung transplant recipient presenting as tenosynovitis, subcutaneous nodules, and liver abscesses.
Journal: Therapeutic advances in infectious disease
Published: August 12, 2022
Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine.
Journal: Open forum infectious diseases
Published: May 27, 2022
A eulogy for Dr Francisco Miguel Marty Forero.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: May 12, 2021
Last Updated: 09/26/2026